The dual-luciferase reporter assay confirmed that miR-204-5p has binding sites with ADAM15, and miR-204-5p can inhibit ADAM15-induced proliferation of NSCLC, which further confirms the tumour promoting function of ADAM15 and provides more clues to the regulation network of ADAM15. This evidence concerns the gene ADAM15 and neoplasm.